Skip to content

Effects of different drugs on block characteristics of selective spinal anesthesia.

Comparison the effect of bupivacaine-dexmedetomidine with bupivacaine-fentanyle on block characeristics of selective spinal anesthesia in patients undergoing leg surgery.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20161031030601N2
Enrollment
90
Registered
2018-02-28
Start date
2018-02-04
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Anaesthesia. Neuraxial anesthesia , Spinal Anaesthesia

Interventions

Intervention 1: In the first intervention group, 5 mg of 0.5% bupivacaine in combination with 5 µg fentanyl, which its volume is brought to 2 ml by adding normal saline, injected into L3-L4 or L4-L5 s

Sponsors

Sanandaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Writing lnformed conscent American socity anesthesilogists physical status1-3 Site of surgery under knee

Exclusion criteria

Exclusion criteria: History of alergy to study drugs. History of lower limb neuropathy. local sepsis of needle insertion site History of coagulopathy. Any contraindication of spinal anesthesia. Hypovolemia.

Design outcomes

Primary

MeasureTime frame
Motor block. Timepoint: 6h-12h-24h after surgery. Method of measurement: Bromage Scale.;Duration of sensory block. Timepoint: Duration of sensory block will be measured by differences between initation of loss of sensation to pinprik and return of sensation in sacral region. Method of measurement: Pinprik test.

Secondary

MeasureTime frame
Pain after surgery. Timepoint: 24h after surgery. Method of measurement: Based on Pain Visual Analogue Scale (VAS) witch is a scale for measurement the intensity of pain.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKarim Nasseri

Sanandaj University of Medical Sciences

bihoshi@gmail.com+98 87 3366 4657

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026